Juan Nieto

Prof. Juan Nieto

Centro Nacional de Análisis Genómico, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2014 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
EREva María Román
Eva María Román
MTMª Teresa Torrades
Mª Teresa Torrades
MNMª Josep Nadal
Mª Josep Nadal
GCGuillem Cárdenas
Guillem Cárdenas
JNJuan Nieto
Juan Nieto
GSGerman Soriano
German Soriano

1 December 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
MSMacarena Simón-Talero
Macarena Simón-Talero
RMRita Garcia Martinez
Rita Garcia Martinez
MTMaria Torrens
Maria Torrens
SASalvador Augustin
Salvador Augustin
SGSusana Gómez
Susana Gómez
JCJuan Córdoba
Juan Córdoba

1 February 2020 in Haematologica
Verified
Journal Article
Open access
PDF file
SBSabela Bobillo
Sabela Bobillo
MCMarta Crespo
Marta Crespo
LELaura Escudero
Laura Escudero
RMRegina Mayor
Regina Mayor
PRPriyanka Raheja
Priyanka Raheja
JSJoan Seoane
Joan Seoane
The levels of cell free circulating tumor DNA (ctDNA) in plasma correlated with treatment response and outcome in systemic lymphomas. Notably, in brain tumors, the levels of ctDNA in the cerebrospinal fluid (CSF) are higher than in plasma. Nevertheless, their role in central nervous system (CNS) lymphomas remains elusive. We evaluated the CSF and plasma from 19 patients: 6 restricted CNS lymphomas, 1 systemic and CNS lymphoma, and 12 systemic lymphomas. We performed whole exome sequencing or targeted sequencing to identify somatic mutations of the primary tumor, then variant-specific droplet digital PCR was designed for each mutation. At time of enrolment, we found ctDNA in the CSF of all patients with restricted CNS lymphoma but not in patients with systemic lymphoma without CNS involvement. Conversely, plasma ctDNA was detected in only 2/6 patients with restricted CNS lymphoma with lower variant allele frequencies than CSF ctDNA. Moreover, we detected CSF ctDNA in 1 patient with CNS lymphoma in complete remission and in 1 patient with systemic lymphoma, 3 and 8 months before CNS relapse was confirmed; indicating CSF ctDNA might detect CNS relapse earlier than conventional methods. Finally, in 2 cases with CNS lymphoma, CSF ctDNA was still detected after treatment even though a complete decrease in CSF tumor cells was observed by flow cytometry (FC), indicating CSF ctDNA better detected residual disease than FC. In conclusion, CSF ctDNA can better detect CNS lesions than plasma ctDNA and FC. In addition, CSF ctDNA predicted CNS relapse in CNS and systemic lymphomas.

12 March 2019 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
EREva Román
Eva Román
JNJuan Nieto
Juan Nieto
CGCristina Gely
Cristina Gely
silvia vidalsilvia vidal
silvia vidal
MPMarta Pozuelo
Marta Pozuelo
GSGerman Soriano
German Soriano
Probiotics can modulate gut microbiota, intestinal permeability, and immune response and could therefore improve cognitive dysfunction and help avoid potential consequences, such as falls, in patients with cirrhosis. The aim of this study was to evaluate the effect of a multistrain probiotic on cognitive function, risk of falls, and inflammatory response in patients with cirrhosis. Consecutive outpatients with cirrhosis and cognitive dysfunction (defined by a Psychometric Hepatic Encephalopathy Score [PHES] < −4) and/or falls in the previous year were randomized to receive either a sachet of a high‐concentration multistrain probiotic containing 450 billion bacteria twice daily for 12 weeks or placebo. We evaluated the changes in cognitive function (PHES); risk of falls (Timed Up and Go [TUG] test, gait speed, and incidence of falls); systemic inflammatory response; neutrophil oxidative burst; intestinal barrier integrity (serum fatty acid–binding protein 6 [FABP‐6] and 2 [FABP‐2] and zonulin and urinary claudin‐3); bacterial translocation (lipopolysaccharide‐binding protein [LBP]); and fecal microbiota. Thirty‐six patients were included. Patients treated with the probiotic (n = 18) showed an improvement in the PHES (P = 0.006), TUG time (P = 0.015) and gait speed (P = 0.02), and a trend toward a lower incidence of falls during follow‐up (0% compared with 22.2% in the placebo group [n = 18]; P = 0.10). In the probiotic group, we observed a decrease in C‐reactive protein (P = 0.01), tumor necrosis factor alpha (P = 0.01), FABP‐6 (P = 0.009), and claudin‐3 (P = 0.002), and an increase in poststimulation neutrophil oxidative burst (P = 0.002). Conclusion: The multistrain probiotic improved cognitive function, risk of falls, and inflammatory response in patients with cirrhosis and cognitive dysfunction and/or previous falls.

3 December 2025 in Nature
Verified
Journal Article
Open access
PDF file
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
ARAndrea Rubio-Ponce
Andrea Rubio-Ponce
MRMathis Richter
Mathis Richter
EPEmanuele Pitino
Emanuele Pitino
IKImmanuel Kwok
Immanuel Kwok
IBIván Ballesteros
Iván Ballesteros
Neutrophils exhibit remarkable phenotypic and functional diversity across tissues and diseases1,2, yet the lack of understanding of how this immune compartment is globally organized challenges translation to the clinic. Here we performed single-cell transcriptional profiling of neutrophils spanning 47 anatomical, physiological and pathological scenarios to generate an integrated map of the global neutrophil compartment in mice, which we refer to as NeuMap. NeuMap integrates and expands existing models3,4 to generate fundamental new insights; it reveals that neutrophils organize in a finite number of functional hubs that distribute sequentially during maturation to then branch out into interferon-responsive and immunosuppressive states, as well as a functionally silent state that dominates in the healthy circulation. Computational modelling and timestamp analyses identify prototypical trajectories that connect these hubs, and reveal that the dynamics and preferred paths vary during health, inflammation and cancer. We show that TGFβ, IFNβ and GM-CSF push neutrophils along the different trajectories, and projection of chromatin accessibility sites onto NeuMap reveals that the transcription factor JUNB controls angiogenic and immunosuppressive states and promotes tissue revascularization. The architecture of NeuMap appears to be conserved across sex, environmental and genetic backgrounds, as well as in humans. Finally, we show that NeuMap enables inference of the pathophysiological state of the host by profiling blood neutrophils. Our study delineates the global architecture of the neutrophil compartment and establishes a framework for exploration and exploitation of neutrophil biology.

7 November 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AHAna Henriques
Ana Henriques
MSMaria Salvany-Celades
Maria Salvany-Celades
PNPaula Nieto
Paula Nieto
SPSergio Palomo-Ponce
Sergio Palomo-Ponce
MSMarta Sevillano
Marta Sevillano
EBEduard Batlle
Eduard Batlle